ROK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | |
PROFIT vs RISK RATING 1..100 | 30 | |
SMR RATING 1..100 | 32 | |
PRICE GROWTH RATING 1..100 | 12 | |
P/E GROWTH RATING 1..100 | 32 | |
SEASONALITY SCORE 1..100 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| PAVE | ROK | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 60% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 58% |
| MACD ODDS (%) | 2 days ago 81% | 2 days ago 49% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 88% | 2 days ago 61% |
| Advances ODDS (%) | 2 days ago 89% | 2 days ago 63% |
| Declines ODDS (%) | 16 days ago 79% | 26 days ago 52% |
| BollingerBands ODDS (%) | 2 days ago 83% | N/A |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 60% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BIB | 89.74 | 1.73 | +1.97% |
| ProShares Ultra Nasdaq Biotechnology | |||
| IBDZ | 25.95 | 0.02 | +0.10% |
| iShares iBonds Dec 2034 Term Corp ETF | |||
| CBOJ | 23.60 | -0.05 | -0.21% |
| Calamos Bitcoin Str Alt Prt ETF-Jan | |||
| DCOR | 80.76 | -0.82 | -1.00% |
| Dimensional US Core Equity 1 ETF | |||
| NBCM | 26.74 | -0.37 | -1.36% |
| Neuberger Commodity Stgy ETF | |||
A.I.dvisor indicates that over the last year, ROK has been closely correlated with EMR. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if ROK jumps, then EMR could also see price increases.